Patents by Inventor Leila JAAFAR-THIEL

Leila JAAFAR-THIEL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SOLID TARGET SYSTEMS FOR THE PRODUCTION OF HIGH-PURITY RADIONUCLIDE COMPOSITIONS
    Publication number: 20240161939
    Abstract: The present disclosure is related to novel solid target systems that produce novel high-purity radionuclide compositions using medical cyclotrons, the compositions are of suitable radionuclidic and chemical purity for use in radiopharmaceutical applications, for example, diagnostic imaging and targeted-radionuclide therapy in nuclear medicine.
    Type: Application
    Filed: September 25, 2023
    Publication date: May 16, 2024
    Applicant: Nuclidium AG
    Inventors: Leila JAAFAR-THIEL, Luqman Mukhtar ISRAD, Attila MOLNAR, Markus Josef BAIER
  • FIBROBLAST ACTIVATION PROTEIN (FAP) INHIBITORS, FAP CONJUGATES, AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF
    Publication number: 20240131203
    Abstract: The present disclosure relates to the field of fibroblast activation protein (FAP) inhibitors, conjugates comprising the novel FAP inhibitors, including radiotracers, for the imaging, diagnosis and treatment of conditions characterized by overexpression of FAP.
    Type: Application
    Filed: September 25, 2023
    Publication date: April 25, 2024
    Applicants: Nuclidium AG, University of Basel
    Inventors: Leila JAAFAR-THIEL, Melpomeni FANI, Jacopo MILLUL, Francesco DE ROSE